3.28
Aclarion Inc stock is traded at $3.28, with a volume of 133.72K.
It is up +4.13% in the last 24 hours and up +0.61% over the past month.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
See More
Previous Close:
$3.15
Open:
$3.24
24h Volume:
133.72K
Relative Volume:
1.33
Market Cap:
$8.08M
Revenue:
$75,700
Net Income/Loss:
$-7.23M
P/E Ratio:
-0.1906
EPS:
-17.2081
Net Cash Flow:
$-7.37M
1W Performance:
+2.18%
1M Performance:
+0.61%
6M Performance:
-47.60%
1Y Performance:
-50.23%
Aclarion Inc Stock (ACON) Company Profile
Name
Aclarion Inc
Sector
Industry
Phone
833 275 2266
Address
8181 ARISTA PLACE, BROOMFIELD
Compare ACON vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ACON
Aclarion Inc
|
3.28 | 7.76M | 75,700 | -7.23M | -7.37M | -17.21 |
|
VEEV
Veeva Systems Inc
|
174.34 | 26.83B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
BTSG
Brightspring Health Services Inc
|
61.68 | 11.80B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
50.47 | 9.21B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
87.99 | 7.59B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
HNGE
Hinge Health Inc
|
56.21 | 4.25B | 646.34M | -512.40M | 202.76M | -6.6871 |
Aclarion Inc Stock (ACON) Latest News
ACON Maintained by Ascendiant Capital -- Price Target Raised to $7.50 - GuruFocus
SentinelOne To Rally Nearly 40%? Here Are 10 Analyst Forecasts For Friday - Benzinga
Aclarion: Board Will Determine Course of Action It Believes Is in Best Interests of Co, Hldrs >ACON - Moomoo
Aclarion to Review Echo Lake Capital’s Unsolicited Proposal - geneonline.com
Aclarion: Echo Lake Communication Contains Numerous Assertions Regarding Governance and Other Matters That Lack Important Context >ACON - Moomoo
Aclarion: Echo Lake Cap Offered to Acquire the Co for $4/Shr in Cash and Contingent Value Rights >ACON - Moomoo
Aclarion, Inc. Comments on Echo Lake Capital’s Letter and Unsolicited Proposal - The Manila Times
Aclarion, Inc. Responds to Echo Lake Capital's Acquisition Proposal and Reaffirms Commitment to Shareholder Value - Quiver Quantitative
Aclarion says board to review Echo Lake Capital's acquisition proposal - marketscreener.com
Aclarion Says Board To Review Echo Lake Capital's Acquisition Proposal - TradingView
Echo Lake Capital Pressures Aclarion Board With Buyout Proposal and Reverse Merger Push - citybiz
Echo Lake Capital Offers To Acquire Aclarion Inc. - marketscreener.com
Echo Lake Capital proposed to acquire Aclarion, Inc.. - marketscreener.com
ACON News | ACLARION INC (NASDAQ:ACON) - ChartMill
Aclarion Inc. (ACON) Slips 1.56% as Shares Approach Key Support at $3.0Hedge Fund Exposure - thelegaladvocate.com
Aclarion Inc. (ACON) Tests Support Zone After 1.56% DeclineAdaptive Moving Average - thelegaladvocate.com
Aclarion Inc. (ACON) Slips 1.8% Amid Low Volume: Support at $3.05 Holds the KeyNHNL Divergence - thelegaladvocate.com
Aclarion Inc. Warrant (ACONW) Declines Sharply, Testing All-Time Low TerritoryBreadth Thrust - Newser
Aclarion Inc. Q1 2026 Earnings: EPS Surpasses Estimates as Company Prioritizes Cost ControlsStock Idea Network - Newser
Aclarion (ACON) upgraded to buy: Here's why - MSN
ACON Stock Price, Quote & Chart | ACLARION INC (NASDAQ:ACON) - ChartMill
Aclarion Q1 2026 Earnings: EPS Surpasses Estimates by 15.2%, Pre-Revenue Stage ContinuesEnergy Earnings Report - Newser
ACONW SEC FilingsACLARION INC 10-K, 10-Q, 8-K Forms - Stock Titan
Aclarion (ACON) Q1 2026 Earnings: $-1.34 EPS Surges Past $-1.58 EstimatesCommunity Watchlist Picks - Newser
Aclarion (ACON) Upgraded to Buy: Here's Why - Yahoo Finance
Aclarion adds Lanman Spinal Neurosurgery to CLARITY trial By Investing.com - Investing.com Nigeria
Why Is Aclarion, Inc. (ACONW) Stock Down Today? - Meyka
Aclarion announces $2.5M stock repurchase plan - MSN
Aclarion (ACON) Crushes Q1 2026 Estimates — EPS $-1.34 Tops ViewsExpert Entry Points - Newser
Aclarion, Inc. (ACON) reports Q1 loss, misses revenue estimates - MSN
Aclarion sees net loss but strengthens cash position - BizWest
ACON SEC FilingsAclarion Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Aclarion, Inc. (ACON) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Aclarion, Inc. 1Q 2026: Revenue $21.1K, EPS $(1.34) — 10-Q Summary - TradingView
Aclarion, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Aclarion (NASDAQ: ACON) widens Q1 2026 loss but boosts cash with $10.4M raise - Stock Titan
Insider Move: Aclarion Director Makes Bold New Share Purchase - TipRanks
Aclarion director Scott Breidbart acquires $18,011 in stock - Investing.com
Aclarion director Scott Breidbart acquires $18,011 in stock By Investing.com - Investing.com Nigeria
Director at Aclarion (ACON) buys 5,664 Common Stock shares in public trade - Stock Titan
Aclarion director David Neal buys $7,750 in company stock By Investing.com - Investing.com Nigeria
Aclarion director David Neal buys $7,750 in company stock - Investing.com
Aclarion (NASDAQ: ACON) director purchases 2,500 shares in open market trade - Stock Titan
TradingKey - TradingKey
Top Executive Makes Bold Insider Move at Aclarion, Inc. - TipRanks
Aclarion Inc Stock (ACON) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):